Abstract | AIM: MATERIALS AND METHODS: RESULTS: In this study, we demonstrated that CCR2 was highly expressed in human and murine periodontitis and that CCR2 deficiency was associated with decreased inflammatory monocyte and macrophage infiltration and inflammatory mediators, osteoclast number and alveolar bone resorption. Prevention and treatment with CVC significantly reduced the severity of periodontitis, regardless of whether it was administered systemically or locally. CONCLUSIONS: CCR2 plays an important role in the development and progression of periodontitis, and CVC is a potential drug for the prevention and treatment of periodontitis.
|
Authors | Wenting Jiang, Tao Xu, Shasha Yuan, Yiping Wei, Zhanming Song, Qingqing Li, Shaoping She, Xuekang Wang, Cui Wang, Gang Yang, Jie Cao, Fei Sun, Meng Shi, Siqi Li, Zhongtian Liu, Yaqian Mo, Ping Lv, Yu Zhang, Ying Wang, Wenjie Hu |
Journal | Journal of clinical periodontology
(J Clin Periodontol)
Vol. 49
Issue 11
Pg. 1203-1216
(Nov 2022)
ISSN: 1600-051X [Electronic] United States |
PMID | 35817437
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Chemical References |
- CCR2 protein, human
- Ccr2 protein, mouse
- Imidazoles
- Inflammation Mediators
- Receptors, CCR2
- Sulfoxides
- cenicriviroc
- Tartrate-Resistant Acid Phosphatase
- Eosine Yellowish-(YS)
|
Topics |
- Alveolar Bone Loss
(drug therapy)
- Animals
- Eosine Yellowish-(YS)
(therapeutic use)
- Humans
- Imidazoles
- Inflammation Mediators
- Mice
- Mice, Inbred C57BL
- Periodontitis
(drug therapy)
- Receptors, CCR2
(metabolism)
- Sulfoxides
- Tartrate-Resistant Acid Phosphatase
- X-Ray Microtomography
|